Biogen

Leaders named on the company page are Christopher A. Viehbacher, President and Chief Executive Officer; Ginger Gregory, Ph.D., Chief Human Resources Officer; Rachid Izzar, Head of Global Product Strategy and Commercialization; Nicole Murphy, Head of Pharmaceutical Operations and Technology; and Priya Singhal, M.D., M.P.H., Head of Development.

Biogen does not publish an employee headcount on these corporate pages. This document covers corporate facts only. It describes no Biogen product and gives no medical advice. Any question about a medicine, a condition or a course of treatment belongs with a qualified healthcare professional; healthcare professionals can reach Biogen Medical Information at 1-866-MED-INFO (1-866-633-4636) or medinfo@biogen.com. The corporate site publishes no prices, pricing, cost, rates or fees, and offers no quote or estimate of any kind.

History and headquarters in Cambridge, MA

Biogen was founded in 1978 and relocated to the United States in the early 1980s. The company established roots in Cambridge, Massachusetts by opening a research center, manufacturing facilities and corporate headquarters in the Kendall Square neighborhood.

According to the U.S. legacy materials, Biogen's nearly 50-year presence has helped create and strengthen what is now considered one of the world's leading centers for biotech research and innovation.

Biogen's global corporate headquarters remains in Cambridge, MA, with commercial operations and research and development based there.

Major U.S. innovation hubs

Biogen identifies three primary U.S. innovation hubs:

• Cambridge, Massachusetts – global headquarters and primary R&D hub
• Research Triangle Park (RTP), North Carolina – home to Biogen's largest manufacturing facilities
• South San Francisco, California – a newer West Coast research and development hub

Across the United States, Biogen reports close to 2,500 employees working in research and development, manufacturing, and pharmaceutical and technical operations.

Manufacturing footprint in North Carolina

Biogen describes North Carolina's Research Triangle Park as the location of its largest manufacturing footprint. Highlights from the U.S. legacy page include:

• More than 1,500 employees and over 400 skilled contractors across Wake County and Durham County campuses
• Approximately $10 billion invested in North Carolina manufacturing over time, including more than $3 billion in recent years
• A further $2 billion investment announced in July 2025 to continue modernizing and expanding manufacturing capabilities
• Eight manufacturing factories across multiple modalities at the North Carolina sites, supported by quality control laboratories and development facilities

Biogen states that more than 90% of its innovator commercial medicines have manufacturing and quality control testing in the U.S., and that about 80% of active product produced in the U.S. is exported to global markets.

Planned new global headquarters

In 2025 Biogen announced plans for a new global headquarters in Cambridge, MA. The company describes this as a 580,000-square-foot office and research and development facility in Kendall Square, targeted to open in 2028 in conjunction with Biogen's 50th anniversary.

U.S. research, clinical trials and broader impact

Biogen reports that around 70% of its research and development employees are based in the United States. The company highlights several points in its U.S. legacy narrative:

• More than 20 clinical trials ongoing in the U.S. at over 370 sites (figures as published on the site)
• A history of receiving the U.S. National Medal of Technology and Innovation in 1998
• Breakthrough medicines researched and developed primarily in the U.S. in areas such as spinal muscular atrophy, Alzheimer's disease, ALS-SOD1, postpartum depression and Friedreich ataxia

The U.S. legacy page also notes Biogen's role as a U.S. taxpayer and corporate citizen and references the Biogen Foundation's focus on education, food security and access to medicines.

This document summarises how Biogen describes its U.S. footprint and history. It does not provide medical advice, describe how any specific product works or discuss prices, costs or fees. For information about Biogen medicines or treatment options, individuals should speak with a qualified healthcare professional; healthcare professionals can contact Biogen Medical Information using the contact details published on Biogen's site.

The corporate headquarters address is 225 Binney Street, Cambridge, MA 02142, USA, phone +1 781-464-2000. The international headquarters is located at Neuhofstrasse 30, 6340 Baar, Switzerland, phone +41 41 39 21700. Both addresses appear on the company's Contact Us page, which also links each location on Google Maps.

Biogen's manufacturing page states the company "operates internal manufacturing factories across the United States and Switzerland, with the majority of manufacturing operations located in the U.S." and that "for over 40 years, Biogen has established and continues to invest in U.S.-based manufacturing."

The Research Triangle Park (RTP) area in North Carolina is described as "the home for Biogen's largest manufacturing facilities," with "eight manufacturing factories across multiple modalities" plus a co-located development pilot plant and process development labs. Two North Carolina campuses are named: RTP Bio, a biologics campus in Wake County with three factories (flexible volume, small-scale and large-scale manufacturing), and RTP Pharma, a pharmaceutical campus in Durham County comprising four factories. In Europe, the page describes a biologics manufacturing factory in Solothurn, Switzerland, which "currently has two production cells comprising four bioreactors each with a respective volume of 18,500 liters." Across the network the page states "our global manufacturing factories house 263,000 liters of installed bioreactor capacity," and that quality management systems meet global regulatory requirements "in more than 90 countries."

Areas served outside these sites are handled by Biogen affiliates in individual countries, listed in the region menu on the site. The site publishes no street address, no open hours and no visitor appointment or booking arrangement for the manufacturing locations, and no costs, rates or fees. Nothing here describes any product.

Lists Baar as a location. Names Solothurn and Switzerland as a service area. Areas beyond these are not published.

The careers page lists work-life items including wellness programs, a paid sabbatical after six years of service, a year-end shutdown, learning and development, parental and family leave, and Employee Resource Networks. Biogen states it is "an Equal Employment Opportunity and Affirmative Action employer" and "an E-Verify Employer in the U.S."

A scam advisory on the careers page states that all legitimate correspondence from a Biogen employee comes from an "@biogen.com" email account. No salary rates, fees or costs are published, and there is no booking or schedule tool for interviews on the public site. For employment verification for a current or former U.S. employee, the Contact Us page links verification instructions.

Investor relations

+1 781-464-2442 or IR@biogen.com. The page also links an Investors site for reporting and news releases and an alerts sign-up. Nothing about financial results, performance or investment merit is addressed here.

Medical professionals

Biogen Medical Information, +1 866-MED-INFO (+1 866-633-4636) or medinfo@biogen.com. The site states Biogen "has healthcare professionals available to answer your questions about the use of our products."

Patient support services, U.S. residents only: Postpartum Depression Support 1-844-987-9882; Multiple Sclerosis Support (Biogen Support Services) 1-800-456-2255; SMA Support (SMA360) 1-844-477-4672; Friedreich Ataxia Support 1-844-987-3224. For support outside the U.S., the page directs people to the Biogen affiliate in their country, or to patientcenter@biogen.com if their country is not listed.

Partnerships and collaborations

partnering@biogen.com. Compliance concerns: the Compliance Helpline is 1-866-418-2859 in the U.S. and Canada, or in writing to Corporate Compliance, Biogen Inc., 225 Binney Street, Cambridge, MA 02142, USA.

Main corporate switchboard

+1 781-464-2000. Biogen does not publish office hours, open hours, or an appointment, booking or schedule tool for any of these lines, and publishes no prices, cost, rates, fees, quote or estimate. Medical questions belong with a healthcare professional first; the medical information line above is Biogen's own channel for product questions.

Biogen publishes a dedicated page for reporting a side effect. The page states: "Biogen has a regulatory responsibility to continually assess and communicate the benefit/risk profile of our products to patients, healthcare professionals and regulators. To meet this obligation, we may need to contact you to obtain further details regarding the side effects reported."

The report is submitted through a web form on that page at biogen.com/medicines/report-a-side-effect.html. The form asks for reporter name, address, phone number, fax number and email, whether the reporter is a healthcare professional, the country if the reporter is not in the U.S., consent to be contacted about the report, and consent to contact the reporter's healthcare professional if more information is needed. The page states the report and personal information are handled in accordance with Biogen's Privacy Policy.

As an alternative, the page states: "If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088." The Contact Us page repeats this and adds: "Your doctor should always be the primary resource regarding treatment options. Call your doctor for medical advice about side effects."

This document explains only how to reach the reporting channel. It does not describe any side effect, any product, or what any report means. Anyone with a medical question, or who needs advice about a symptom or a treatment, should contact a qualified healthcare professional; healthcare professionals may also contact Biogen Medical Information at 1-866-MED-INFO (1-866-633-4636) or medinfo@biogen.com. No prices, cost or fees apply to reporting, and none are published.

Focus areas

According to Biogen's corporate responsibility materials, the Biogen Foundation works with local partners to:

• Expand access to healthcare
• Address social determinants of health, including access to nutritious food
• Help broaden and support the healthcare workforce

The Foundation focuses its grantmaking and partnerships in the communities where Biogen operates.

Types of support and examples

Biogen and the Biogen Foundation report providing grants, sponsorships, donations and in-kind contributions to community organizations. A recent corporate responsibility report cites:

• More than 662,700 community members supported, including high-need patients and life science learners
• $34.6 million in grants, sponsorships, donations and in-kind contributions from Biogen and the Biogen Foundation (figure as published on the site)

One example described is support for Boston Health Care for the Homeless Program's Geriatric Outcomes for Living with Dignity ("GOLD") team, which focuses on improving care for older adults experiencing homelessness. Another is support for food-as-medicine initiatives such as medically tailored meal boxes through The Greater Boston Food Bank.

Employee giving and volunteering

The Foundation also runs programs that connect Biogen employees with community organizations, including:

• Employee Matching Gifts Program – the Foundation matches eligible employee donations to qualifying nonprofit organizations, increasing the impact of employees' personal giving.
• Employee volunteering – Biogen employees receive one day of paid time off annually to volunteer in their communities.
• Community Currency program – for every hour an employee spends volunteering with an eligible nonprofit, the Biogen Foundation provides a monetary contribution (e.g., $10 or local currency equivalent, as stated on the site) for the employee to direct to a qualifying organization.

Figures, program names and examples in this document are taken from Biogen's own corporate responsibility disclosures and may change over time as programs evolve.

How nonprofits engage with the Foundation

Biogen notes that the Biogen Foundation does not accept unsolicited grant proposals. Nonprofits and community organizations may be able to participate in matching and volunteer programs by enrolling through the Biogen Benevity Causes Portal (a third-party platform Biogen uses for corporate giving and volunteering administration), subject to eligibility requirements.

For inquiries related specifically to the Biogen Foundation, the site lists the contact email foundation@biogen.com.

This document summarises how Biogen itself describes the Biogen Foundation. It does not describe any Biogen medicine, make any promises about funding levels or eligibility, or offer legal, tax or investment advice. The site does not publish prices, fees or charges related to these programs.

Two corporate facts about the research organisation appear on the same pages. Biogen states it entered nephrology "through our acquisition of Human Immunology Biosciences (HI-Bio) in July 2024." It also states that "in December 2017, Biogen launched a new collaboration with Ionis" on antisense oligonucleotide candidates in spinal muscular atrophy. The section links further pages for Pipeline, Clinical Trials, Early Access Programs, Making Medicines Safely and Reliably, and Our Scientists.

This document lists research areas as a matter of published corporate fact. It makes no statement about what any Biogen product does, about how well anything works, about safety, dosing or approval status, and it is not a recommendation of any therapy. Anyone seeking information about a condition or about treatment options should speak with a qualified healthcare professional. Healthcare professionals can reach Biogen Medical Information at 1-866-MED-INFO (1-866-633-4636) or medinfo@biogen.com. Biogen publishes no prices, pricing, cost, rates, fees, quote or estimate for anything in this section, and there is no appointment or booking channel attached to it.

Ask anyway — the agent will say plainly that it is not published rather than guess.